Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 89

1.

Genome-wide association studies identify polygenic effects for completed suicide in the Japanese population.

Otsuka I, Akiyama M, Shirakawa O, Okazaki S, Momozawa Y, Kamatani Y, Izumi T, Numata S, Takahashi M, Boku S, Sora I, Yamamoto K, Ueno Y, Toda T, Kubo M, Hishimoto A.

Neuropsychopharmacology. 2019 Sep 2. doi: 10.1038/s41386-019-0506-5. [Epub ahead of print]

PMID:
31476763
2.

Improvement of psychiatrists' clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study.

Takaesu Y, Watanabe K, Numata S, Iwata M, Kudo N, Oishi S, Takizawa T, Nemoto K, Yasuda Y, Tagata H, Tsuboi T, Tsujino N, Hashimoto N, Matsui Y, Hori H, Yamamori H, Sugiyama N, Suwa T, Kishimoto T, Hishimoto A, Usami M, Furihata R, Iwamoto K, Fujishiro H, Nakamura T, Mizuno K, Inagaki T, Katsumoto E, Tomita H, Ohi K, Muraoka H, Atake K, Iida H, Nagasawa T, Fujita J, Yamamura S, Onitsuka T, Murata A, Takayanagi Y, Noda H, Matsumura Y, Takezawa K, Iga JI, Ichihashi K, Ogasawara K, Yamada H, Inada K, Hashimoto R.

Psychiatry Clin Neurosci. 2019 Aug 22. doi: 10.1111/pcn.12911. [Epub ahead of print]

PMID:
31437336
3.

Mitochondrial DNA Copy Number Raises the Potential of Left Frontopolar Hemodynamic Response as a Diagnostic Marker for Distinguishing Bipolar Disorder From Major Depressive Disorder.

Tsujii N, Otsuka I, Okazaki S, Yanagi M, Numata S, Yamaki N, Kawakubo Y, Shirakawa O, Hishimoto A.

Front Psychiatry. 2019 May 8;10:312. doi: 10.3389/fpsyt.2019.00312. eCollection 2019.

4.

Epigenetic clock analysis of blood samples from Japanese schizophrenia patients.

Okazaki S, Otsuka I, Numata S, Horai T, Mouri K, Boku S, Ohmori T, Sora I, Hishimoto A.

NPJ Schizophr. 2019 Feb 27;5(1):4. doi: 10.1038/s41537-019-0072-1.

5.

Clinical factors influencing resilience in patients with anorexia nervosa.

Kane C, Tomotake M, Hamatani S, Chiba S, Kameoka N, Watanabe S, Nakataki M, Numata S, Ohmori T.

Neuropsychiatr Dis Treat. 2019 Jan 30;15:391-395. doi: 10.2147/NDT.S190725. eCollection 2019.

6.

Negative and positive self-thoughts predict subjective quality of life in people with schizophrenia.

Takeda T, Nakataki M, Ohta M, Hamatani S, Matsuura K, Yoshida R, Kameoka N, Tominaga T, Umehara H, Kinoshita M, Watanabe S, Numata S, Sumitani S, Ohmori T.

Neuropsychiatr Dis Treat. 2019 Jan 21;15:293-301. doi: 10.2147/NDT.S190381. eCollection 2019.

7.

Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and Agranulocytosis.

Numata S, Umehara H, Ohmori T, Hashimoto R.

Front Pharmacol. 2018 Sep 26;9:1049. doi: 10.3389/fphar.2018.01049. eCollection 2018. Review.

8.

Relationship between social and cognitive functions in people with schizophrenia.

Tominaga T, Tomotake M, Takeda T, Ueoka Y, Tanaka T, Watanabe SY, Kameoka N, Nakataki M, Numata S, Izaki Y, Sumitani S, Kubo H, Kaneda Y, Ohmori T.

Neuropsychiatr Dis Treat. 2018 Aug 30;14:2215-2224. doi: 10.2147/NDT.S171207. eCollection 2018.

9.

Comparative Analyses of Copy-Number Variation in Autism Spectrum Disorder and Schizophrenia Reveal Etiological Overlap and Biological Insights.

Kushima I, Aleksic B, Nakatochi M, Shimamura T, Okada T, Uno Y, Morikawa M, Ishizuka K, Shiino T, Kimura H, Arioka Y, Yoshimi A, Takasaki Y, Yu Y, Nakamura Y, Yamamoto M, Iidaka T, Iritani S, Inada T, Ogawa N, Shishido E, Torii Y, Kawano N, Omura Y, Yoshikawa T, Uchiyama T, Yamamoto T, Ikeda M, Hashimoto R, Yamamori H, Yasuda Y, Someya T, Watanabe Y, Egawa J, Nunokawa A, Itokawa M, Arai M, Miyashita M, Kobori A, Suzuki M, Takahashi T, Usami M, Kodaira M, Watanabe K, Sasaki T, Kuwabara H, Tochigi M, Nishimura F, Yamasue H, Eriguchi Y, Benner S, Kojima M, Yassin W, Munesue T, Yokoyama S, Kimura R, Funabiki Y, Kosaka H, Ishitobi M, Ohmori T, Numata S, Yoshikawa T, Toyota T, Yamakawa K, Suzuki T, Inoue Y, Nakaoka K, Goto YI, Inagaki M, Hashimoto N, Kusumi I, Son S, Murai T, Ikegame T, Okada N, Kasai K, Kunimoto S, Mori D, Iwata N, Ozaki N.

Cell Rep. 2018 Sep 11;24(11):2838-2856. doi: 10.1016/j.celrep.2018.08.022.

10.

Mitochondrial DNA copy number of peripheral blood in bipolar disorder: The present study and a meta-analysis.

Yamaki N, Otsuka I, Numata S, Yanagi M, Mouri K, Okazaki S, Boku S, Horai T, Ohmori T, Shirakawa O, Sora I, Hishimoto A.

Psychiatry Res. 2018 Nov;269:115-117. doi: 10.1016/j.psychres.2018.08.014. Epub 2018 Aug 18.

PMID:
30145290
11.

Structural equation modeling approach between salience network dysfunction, depressed mood, and subjective quality of life in schizophrenia: an ICA resting-state fMRI study.

Ohta M, Nakataki M, Takeda T, Numata S, Tominaga T, Kameoka N, Kubo H, Kinoshita M, Matsuura K, Otomo M, Takeichi N, Harada M, Ohmori T.

Neuropsychiatr Dis Treat. 2018 Jun 15;14:1585-1597. doi: 10.2147/NDT.S163132. eCollection 2018.

12.

Longer telomeres in elderly schizophrenia are associated with long-term hospitalization in the Japanese population.

Zhang Y, Hishimoto A, Otsuka I, Watanabe Y, Numata S, Yamamori H, Boku S, Horai T, Someya T, Ohmori T, Hashimoto R, Sora I.

J Psychiatr Res. 2018 Aug;103:161-166. doi: 10.1016/j.jpsychires.2018.05.014. Epub 2018 May 21.

PMID:
29870917
13.

Decreased serum pyridoxal levels in schizophrenia: meta-analysis and Mendelian randomization analysis.

Tomioka Y, Numata S, Kinoshita M, Umehara H, Watanabe SY, Nakataki M, Iwayama Y, Toyota T, Ikeda M, Yamamori H, Shimodera S, Tajima A, Hashimoto R, Iwata N, Yoshikawa T, Ohmori T.

J Psychiatry Neurosci. 2018 May;43(3):194-200.

14.

Elevated peripheral blood glutamate levels in major depressive disorder.

Inoshita M, Umehara H, Watanabe SY, Nakataki M, Kinoshita M, Tomioka Y, Tajima A, Numata S, Ohmori T.

Neuropsychiatr Dis Treat. 2018 Apr 6;14:945-953. doi: 10.2147/NDT.S159855. eCollection 2018.

15.

Plasma Levels of Soluble Tumor Necrosis Factor Receptor 2 (sTNFR2) Are Associated with Hippocampal Volume and Cognitive Performance in Patients with Schizophrenia.

Kudo N, Yamamori H, Ishima T, Nemoto K, Yasuda Y, Fujimoto M, Azechi H, Niitsu T, Numata S, Ikeda M, Iyo M, Ohmori T, Fukunaga M, Watanabe Y, Hashimoto K, Hashimoto R.

Int J Neuropsychopharmacol. 2018 Jul 1;21(7):631-639. doi: 10.1093/ijnp/pyy013.

16.

Retraction: A significant causal association between C-reactive protein levels and schizophrenia.

Inoshita M, Numata S, Tajima A, Kinoshita M, Umehara H, Nakataki M, Ikeda M, Maruyama S, Yamamori H, Kanazawa T, Shimodera S, Hashimoto R, Imoto I, Yoneda H, Iwata N, Ohmori T.

Sci Rep. 2018 Feb 21;8:46947. doi: 10.1038/srep46947.

17.

Decreased serum pyridoxal levels in schizophrenia: meta-analysis and Mendelian randomization analysis.

Tomioka Y, Numata S, Kinoshita M, Umehara H, Watanabe SY, Nakataki M, Iwayama Y, Toyota T, Ikeda M, Yamamori H, Shimodera S, Tajima A, Hashimoto R, Iwata N, Yoshikawa T, Ohmori T.

J Psychiatry Neurosci. 2018 Feb 2;43(2):170053. doi: 10.1503/jpn.170053. [Epub ahead of print]

18.

Increased serum levels and promoter polymorphisms of macrophage migration inhibitory factor in schizophrenia.

Okazaki S, Hishimoto A, Otsuka I, Watanabe Y, Numata S, Boku S, Shimmyo N, Kinoshita M, Inoue E, Ohmori T, Someya T, Sora I.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Apr 20;83:33-41. doi: 10.1016/j.pnpbp.2018.01.001. Epub 2018 Jan 2.

PMID:
29305329
19.

Altered KYN/TRP, Gln/Glu, and Met/methionine sulfoxide ratios in the blood plasma of medication-free patients with major depressive disorder.

Umehara H, Numata S, Watanabe SY, Hatakeyama Y, Kinoshita M, Tomioka Y, Nakahara K, Nikawa T, Ohmori T.

Sci Rep. 2017 Jul 7;7(1):4855. doi: 10.1038/s41598-017-05121-6.

20.

De novo non-synonymous TBL1XR1 mutation alters Wnt signaling activity.

Nishi A, Numata S, Tajima A, Zhu X, Ito K, Saito A, Kato Y, Kinoshita M, Shimodera S, Ono S, Ochi S, Imamura A, Kurotaki N, Ueno SI, Iwata N, Fukui K, Imoto I, Kamiya A, Ohmori T.

Sci Rep. 2017 Jun 6;7(1):2887. doi: 10.1038/s41598-017-02792-z.

Supplemental Content

Loading ...
Support Center